Category: Forensic Toxicology

Rare GLP-1 Side Effects: Evidence and Warning Signs

Short answer: Most side effects of GLP-1–based medicines are gastrointestinal, but uncommon serious problems can include pancreatitis, gallbladder disease, kidney injury from dehydration, severe allergic reactions, and complications from delayed stomach emptying. Risks and label language differ by drug and indication. Reviewed and updated July 24, 2026. “GLP-1” is not…

Depo-Provera and Meningioma Risk: What Studies Show

Short answer: Several large observational studies report an association between depot medroxyprogesterone acetate (DMPA, commonly known as Depo-Provera) and meningioma, especially with prolonged exposure. The studies do not prove that the drug caused an individual tumor, and relative risk is not the same as absolute risk. Reviewed and updated July…

Lamotrigine and Stevens-Johnson Syndrome: Warning Signs

Short answer: Lamotrigine (Lamictal) can cause rare, life-threatening skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Because a harmless rash cannot always be distinguished early from a serious one, a new rash requires prompt medical advice. Reviewed and updated July 24, 2026. What the boxed warning says The FDA-approved…

Pink Cocaine (Tusi): What It Contains and Why It Is Risky

Short answer: “Pink cocaine,” often called tusi or tucibi, is not a standardized drug. It is usually a dyed mixture of other substances and often contains neither cocaine nor 2C-B. The greatest danger is that the ingredients and strength can change from batch to batch. Reviewed and updated July 24,…

Ninth Circuit Open-Carry Decisions: What They Mean

A Ninth Circuit panel struck down the urban open-carry ban in January. The full court has since voted to rehear the case and vacated that opinion. The ban remains in force for now.

California’s Age-Appropriate Design Code Act Decision

On its second look at the Age-Appropriate Design Code, the Ninth Circuit put the age-estimation rule back in play while keeping the data-use and “dark patterns” provisions frozen for vagueness. A compliance map for services likely accessed by minors.

Drug Recognition Expert (DRE) Program Analysis

Anatomy of a forensic illusion: why the “Drug Recognition Expert” evaluation looks like science, and why its own validation studies prove almost nothing.

Kosecki 2023 Blood-Fermentation Study: Limits and Evidence

A 2023 paper is increasingly cited to shut down “fermentation” defenses in DUI cases. Read closely, it answers a question no one was asking — and the literature it cites cuts the other way.

Anabolic-Androgenic Steroids: Effects, Risks and Testing

Pharmacokinetics, detection science, clinical profile, and litigation use for attorneys, judges, and forensic professionals

What the Largest U.S. Government Drugged-Driving Study Found

When prosecutors, the press, or a juror’s intuition tell you that “drugs cause crashes,” there is one study they should be made to confront: the 2015 NHTSA case-control study by Richard Compton and Amy Berning, Drug and Alcohol Crash Risk (DOT HS 812 117). It remains the largest, most carefully…

Kitagawa Balloon Test: History, Validation and Limitations

The Kitagawa balloon test, more precisely the Kitagawa-Wright detector-tube method, is sometimes treated in courtrooms and older case files as if it were a scientifically grounded measurement of blood-alcohol concentration . It is not. The most striking feature of the historical record is that the…

Why Doesn’t Blood Ferment in Living People?

Short answer: Blood in a healthy living person does not behave like a fermentation vessel because it normally contains no stable, growing microbial community. Microbes that enter briefly are usually removed by immune defenses, the liver, and the spleen before they can establish an infection. Oxygen, blood flow, and glucose…

The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Oral THC Affected Cognition Without a Parallel Symptom-Scale Increase in a Schizophrenia Study

An oral THC condition worsened selected cognitive outcomes without a significant parallel increase in measured psychotic symptoms several hours later. That combination of findings does not show that THC is harmless in schizophrenia or that all routes have identical effects. Several populations and treatment conditions The double-dummy laboratory study involved…

Read Article: Oral THC Affected Cognition Without a Parallel Symptom-Scale Increase in a Schizophrenia Study

CBD-Associated Liver Enzyme Elevations Occurred Without Reported Liver Symptoms

Healthy adults developed elevated liver enzymes during a four-week CBD trial despite not reporting corresponding liver-related symptoms. The finding shows why the absence of symptoms cannot substitute for the laboratory endpoint being studied. A repeated-dose randomized trial The trial involved 201 healthy participants overall and compared CBD at 5 mg/kg…

Read Article: CBD-Associated Liver Enzyme Elevations Occurred Without Reported Liver Symptoms

CBD–Terpene Sleep Trial: The Average Effect Was Smaller Than the Best-Responder Result

A CBD–terpene trial found a small average change in wearable-estimated sleep stages, while the largest reported improvements occurred in selected responders. Those responder figures should not be presented as the expected benefit for everyone with insomnia. A combined formulation and incomplete datasets The study used 300 mg CBD with eight…

Read Article: CBD–Terpene Sleep Trial: The Average Effect Was Smaller Than the Best-Responder Result